Biome Australia – FY24 Revenue Guidance Upgrade to $12.5M
On Monday this week, Biome Australia Limited (ASX: BIO) announced an upgrade to their FY2024 revenue forecast from $11.5m to… Read more
On Monday this week, Biome Australia Limited (ASX: BIO) announced an upgrade to their FY2024 revenue forecast from $11.5m to… Read more
Happy New Year from Canary Capital. Biome Australia has this morning announced record sales revenue for both the December quarter… Read more
What an incredible year it has been for Biome Australia Limited (ASX: BIO). Biome Activated Probiotics is now the fastest growing… Read more
Biome Australia Limited (ASX:BIO) announced this morning that they have signed a landmark agreement with one of its key probiotic… Read more
Microbiome health company, Biome Australia Limited (ASX:BIO, “Biome” or “the Company”), announces in accordance with Listing Rule 3.13.2 and Section… Read more
Revenue Update • Biome surpasses $5m sales revenue for the first five months of the financial year FY24, representing 70%… Read more
● Biome reports record $2.74m sales revenue in Q1 FY24 ● 59% gross margin maintained for Q1 FY24 ● Same-store… Read more
● Biome expects to achieve positive monthly EBITDA by June 2024 ● Gross margins expected to be maintained above 59%… Read more
● Q1 FY24 Sales reach $2.74m, 74% growth vs the previous corresponding period ● Biome surpasses Q1 FY24 revenue target… Read more